MDS appoints CEO, CFO from within
Life sciences company MDS has appointed Steve West, former president of MDS Nordion and chief operating officer of MDS, to the position of CEO of the parent company and member of its board of directors.
West replaces Stephen P. DeFalco. The Ottawa-based company also announced that effective Feb. 1, Peter Dans, current senior vice president of finance at MDS, will become chief financial officer (CFO), replacing current executive vice president and CFO of MDS, Doug Prince.
Dans and Prince will work together during the transition period to ensure the planned share buyback and sale of the MDS Pharma Services Early Stage business, as well as other company actions regarding its repositioning plan will be continuously supported, said the company.
West replaces Stephen P. DeFalco. The Ottawa-based company also announced that effective Feb. 1, Peter Dans, current senior vice president of finance at MDS, will become chief financial officer (CFO), replacing current executive vice president and CFO of MDS, Doug Prince.
Dans and Prince will work together during the transition period to ensure the planned share buyback and sale of the MDS Pharma Services Early Stage business, as well as other company actions regarding its repositioning plan will be continuously supported, said the company.